Physician profile
Troy C Ellis
NPI 1356491997
$14,179.13
in general payments reported to CMS, 2019-2025
33 companies · $2,463 in 2025
The $2,463 reported for 2025 was more than what 81% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,156 · 2020: $525 · 2021: $2,354 · 2022: $1,953 · 2023: $2,790 · 2024: $2,939 · 2025: $2,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,813 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $208 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,813.23 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $208.12 |
| Education | $169.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,744.09 | 2019-2025 | |
| Abbott Laboratories | $2,088.00 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Janssen Biotech, INC. | $904.25 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $764.95 | 2019-2025 | Blu-U, Odomzo, Ilumya |
| Amgen INC. | $744.34 | 2019-2025 | Otezla, Enbrel, Otezla |
| Ucb, INC. | $730.51 | 2019-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $713.77 | 2019-2025 | Libtayo, Dupixent |
| Dermavant Sciences, INC. | $657.33 | 2023-2024 | Vtama |
| Biofrontera INC. | $642.41 | 2021 | |
| Leo Pharma INC. | $591.33 | 2019-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $435.49 | 2022-2025 | Sotyktu, Camzyos |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $407.18 | 2019-2025 | Jublia |
| Lilly USA, LLC | $398.32 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Pfizer INC. | $377.56 | 2019-2024 | |
| Genzyme Corporation | $308.49 | 2019-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $280.22 | 2019-2022 | |
| Galderma Laboratories, L.P. | $234.30 | 2019-2025 | Nemluvio |
| Incyte Corporation | $229.69 | 2021-2025 | Opzelura |
| Almirall LLC | $179.50 | 2019-2025 | Klisyri, Seysara |
| Arcutis Biotherapeutics, INC. | $152.01 | 2023-2024 | Zoryve |
| Medtronic, INC. | $98.31 | 2025 | Minimed 780g |
| Mayne Pharma Commercial LLC | $75.75 | 2019-2025 | |
| Organon LLC | $65.13 | 2025 | Vtama |
| Helsinn Therapeutics (U.S.), INC. | $62.07 | 2021-2025 | Valchlor |
| Novartis Pharmaceuticals Corporation | $56.34 | 2024-2025 | |
| Celgene Corporation | $49.43 | 2019 | |
| Organogenesis INC. | $43.02 | 2023 | Puraply |
| Kyowa Kirin, INC. | $42.01 | 2021 | |
| Epi Health, LLC | $26.63 | 2022 | |
| Surgenex LLC | $23.32 | 2025 | Renograft, Ardeograft, Surgraft |
| Journey Medical Corporation | $23.23 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.87 | 2023 | Cyltezo |
| Dermira, INC. | $14.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.